SCHEMBL24309643

SCHEMBL24309643

Cc1cccc(C)c1-c1cc(Oc2cccc(C/C=C/C(=O)O)c2)nc(NSc2cccc([N+](=O)[O-])c2)n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 1/20 0.33
▸ F10 P00742 1/20 0.33
▸ PLAU P00749 1/20 0.32
▸ MEN1 O00255 5/20 0.32
▸ KMT2A Q03164 5/20 0.32
▸ MAPT P10636 4/20 0.32
▸ CYP2C19 P33261 3/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ CYP2C9 P11712 2/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ CRHBP P24387 1/20 0.32
▸ CRHR2 Q13324 1/20 0.32
▸ MAOB P27338 1/20 0.31
▸ CDK4 P11802 1/20 0.31
▸ CDK2 P24941 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24330506 0.86 PGR (0.42) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL29566821 0.86 PGR (0.42) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL24330507 0.74 FFAR1 (0.33) FFAR1F10MAPTCYP2C19ALDH1A1
SCHEMBL24310597 0.74 TDP1 (0.44) KMT2AMAPTALDH1A1
SCHEMBL29566742 0.73 LMNA (0.43) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL24330505 0.73 LMNA (0.43) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL24330653 0.73 FFAR1 (0.38) FFAR1
SCHEMBL24310009 0.72 GPR39 (0.45) MEN1KMT2AMAPTCYP2C19ALDH1A1
SCHEMBL24298101 0.72 ALDH1A1 (0.41) MEN1KMT2AMAPTCYP3A4ALDH1A1
SCHEMBL24298137 0.71 GPR39 (0.35) F10MEN1KMT2AMAPTCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback